Accomplishments 2003
(Diabetes) Oral Insulin: New tablet prototype created
- Presented two Type 2 patient studies at the ADA annual meeting (glucose clamp and overnight studies)
- Completed Fed Study
- Initiated Phase I testing under U.S. IND
(Anticoagulants) Solid Oral UF Heparin: Improved tablet prototype formulation
(Osteoporosis) Oral Salmon Calcitonin: Achieved statistically significant results from a Phase IIa study with Novartis AG
Feasibility Programs
- (Anthrax) Oral antigen collaboration with U.S. Army (USAMRIID)
- (Obesity) PYY3-36 : Rodent data; advanced to primate testing